These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38761162)

  • 1. Emerging drugs for the treatment of short bowel syndrome.
    Frau T; El Khatib M; De Dreuille B; Billiauws L; Nuzzo A; Joly F
    Expert Opin Emerg Drugs; 2024 Sep; 29(3):277-288. PubMed ID: 38761162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological Characterization of Apraglutide, a Novel Long-Acting Peptidic Glucagon-Like Peptide-2 Agonist, for the Treatment of Short Bowel Syndrome.
    Hargrove DM; Alagarsamy S; Croston G; Laporte R; Qi S; Srinivasan K; Sueiras-Diaz J; Wiśniewski K; Hartwig J; Lu M; Posch AP; Wiśniewska H; Schteingart CD; Rivière PJ; Dimitriadou V
    J Pharmacol Exp Ther; 2020 May; 373(2):193-203. PubMed ID: 32075870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The safety of available treatment options for short bowel syndrome and unmet needs.
    Pironi L; Raschi E; Sasdelli AS
    Expert Opin Drug Saf; 2021 Dec; 20(12):1501-1513. PubMed ID: 34105428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Potential of GLP-2 Analogs in Gastrointestinal Disorders: Current Knowledge, Nutritional Aspects, and Future Perspectives.
    Kounatidis D; Vallianou NG; Tsilingiris D; Christodoulatos GS; Geladari E; Stratigou T; Karampela I; Dalamaga M
    Curr Nutr Rep; 2022 Dec; 11(4):618-642. PubMed ID: 35933503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of glucagon-like peptide 2 in patients with short bowel syndrome: a systematic review and network meta-analysis.
    Sabra HK; Remeih GS; Kereet IM; Hamad M; Ahmed YA; Jahangir K; Bakr MA; Alagelli FA; Sherif H; Elsaid M
    J Gastrointest Surg; 2024 Jul; 28(7):1194-1205. PubMed ID: 38663565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Teduglutide for the treatment of short bowel syndrome - a safety evaluation.
    Kochar B; Herfarth HH
    Expert Opin Drug Saf; 2018 Jul; 17(7):733-739. PubMed ID: 29848084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The indications and results of the use of teduglutide in patients with short bowel.
    El Khatib M; Billiauws L; Joly F
    Curr Opin Clin Nutr Metab Care; 2023 Sep; 26(5):449-454. PubMed ID: 37421385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging treatment options for short bowel syndrome: potential role of teduglutide.
    Tee CT; Wallis K; Gabe SM
    Clin Exp Gastroenterol; 2011; 4():189-96. PubMed ID: 22016579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon-like peptide-2 analogues for Crohn's disease patients with short bowel syndrome and intestinal failure.
    Pizzoferrato M; Puca P; Ennas S; Cammarota G; Guidi L
    World J Gastroenterol; 2022 Nov; 28(44):6258-6270. PubMed ID: 36504557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The new place of enterohormones in intestinal failure.
    Daoud DC; Joly F
    Curr Opin Clin Nutr Metab Care; 2020 Sep; 23(5):344-349. PubMed ID: 32618723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An updated overview of glucagon-like peptide-2 analog trophic therapy for short bowel syndrome in adults.
    Zhu C; Li Y
    J Int Med Res; 2022 Mar; 50(3):3000605221086145. PubMed ID: 35343263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HM15912, a Novel Long-Acting Glucagon-Like Peptide-2 Analog, Improves Intestinal Growth and Absorption Capacity in a Male Rat Model of Short Bowel Syndrome.
    Choi J; Lee J; Park E; Kwon H; Kim D; Bae S; Choi IY; Kim HH
    J Pharmacol Exp Ther; 2023 Feb; 384(2):277-286. PubMed ID: 36410792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating short bowel syndrome with pharmacotherapy.
    Hollanda Martins Da Rocha M; Lee ADW; Marin MLM; Faintuch S; Mishaly A; Faintuch J
    Expert Opin Pharmacother; 2020 Apr; 21(6):709-720. PubMed ID: 32057270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic options for intestinal rehabilitation in patients with short bowel syndrome.
    Jeppesen PB
    JPEN J Parenter Enteral Nutr; 2014 May; 38(1 Suppl):45S-52S. PubMed ID: 24615689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of teduglutide in adults with short bowel syndrome-associated intestinal failure.
    Pironi L; Allard JP; Joly F; Geransar P; Genestin E; Pape UF
    Nutr Clin Pract; 2024 Feb; 39(1):141-153. PubMed ID: 37294295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translation of Evidence Into Practice With Teduglutide in the Management of Adults With Intestinal Failure due to Short-Bowel Syndrome: A Review of Recent Literature.
    Pironi L
    JPEN J Parenter Enteral Nutr; 2020 Aug; 44(6):968-978. PubMed ID: 31802516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience with teduglutide treatment for short bowel syndrome in clinical practice.
    Pevny S; Maasberg S; Rieger A; Karber M; Blüthner E; Knappe-Drzikova B; Thurmann D; Büttner J; Weylandt KH; Wiedenmann B; Müller VA; Bläker H; Pascher A; Pape UF
    Clin Nutr; 2019 Aug; 38(4):1745-1755. PubMed ID: 30145039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of short bowel syndrome: Breaking the therapeutic ceiling?
    Wauters L; Joly F
    Nutr Clin Pract; 2023 May; 38 Suppl 1():S76-S87. PubMed ID: 37115030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-Marketing Use of Teduglutide in a Large Cohort of Adults with Short Bowel Syndrome-Associated Chronic Intestinal Failure: Evolution and Outcomes.
    de Dreuille B; Nuzzo A; Bataille J; Mailhat C; Billiauws L; Le Gall M; Joly F
    Nutrients; 2023 May; 15(11):. PubMed ID: 37299413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life in patients with short bowel syndrome treated with the new glucagon-like peptide-2 analogue teduglutide--analyses from a randomised, placebo-controlled study.
    Jeppesen PB; Pertkiewicz M; Forbes A; Pironi L; Gabe SM; Joly F; Messing B; Loth S; Youssef NN; Heinze H; Berghöfer P
    Clin Nutr; 2013 Oct; 32(5):713-21. PubMed ID: 23587733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.